Promising biobased alternatives to substances of very high concern There are many possible biobased alternatives to substances of very high concern (SVHC). Some are even ready to be deployed right away.
European Antibiotic Awareness Day 2014 Tuesday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe, attention is focused on the responsible use of antibiotics for people and animals.
Partnering as effective strategy to bring new drugs to European market Combining strengths in drug discovery and development by partnering with a medium- or large-sized pharmaceutical company increases the likelihood of success in bringing new products to the market f
Dr. ZhiChao Dang appointed honorary professor in China Dr. ZhiChao Dang of the National Institute of Public Health and Environment (RIVM) was appointed honorary professor at the highly renowned Nanjing Institute of Environmental Sciences (NIES).
The National Immunisation Programme in the Netherlands 2013 - 2014 Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).
Point-of-care testing in nursing homes in the Netherlands RIVM has conducted an explorative study on the use of point-of-care (POC) tests in nursing homes.
Personalised medicine provides optimal treatment In personalised medicine, patients are treated with medicinal products according to their individual characteristics, such as genetic background, instead of a traditional one-size-fits-all approach
Jaap van Dissel appointed as Director of the RIVM Centre for Infectious Disease Control Prof Jaap van Dissel is appointed as Director of the RIVM Centre for Infectious Disease Control. He takes up the post on 15 August and succeeds Prof.
Extra measles vaccinations for risk groups Some areas of the Netherlands where families for religious reasons chose not to get their babies vaccinated are now reporting cases of measles, and it is expected that the number of cases will incr
Fewer municipalities with low vaccination coverage In the Netherlands, there are 80 municipalities with a low vaccination coverage for one or more vaccinations. This is a decrease compared to last year when there were still 90 municipalities.